Inba Pharma Private Limited
About Inba Pharma Private Limited
Data last updated:
Inba Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Arc International Fertility And Research Centre Private Limited. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 29 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85300TN2021PTC145107. Its GSTIN is 33AAVCA5534F1ZL (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Joshitt and Pramodita.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.50 & 51 3rd Street Balajinagar Padi, Chennai, Tamil Nadu, India – 600050.
As per the financials filed for FY 2024, the company reported a revenue of ₹87.93 Lakh, a decline of 65% compared to the previous year. For the same year it recorded a net loss of ₹4.36 Lakh (net margin -5%) and EBITDA of ₹6.86 Lakh (EBITDA margin 7.8%).
The company has about 16 employees on its provident fund (EPFO) records.
Company details
Contact details
Inba Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.50 & 51 3rd Street Balajinagar Padi, Chennai, Tamil Nadu, India – 600050
- IndustryHealthcare, Hospitals
To see the full contact details of Inba Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inba Pharma is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Inba Pharma Private Limited, buy the company report.
Financials of Inba Pharma Private Limited
FY 2024 filings availableInba Pharma Private Limited reported revenue of ₹87.93 Lakh (down 65% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 65% in the latest year. EBITDA fell 78% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹87.93 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹6.86 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹4.36 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 7.8% | ||
| Net Profit Margin | -5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Inba Pharma Private Limited, buy the company report.
Board of directors of Inba Pharma Private Limited
Inba Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Joshitt | Director | 23 Feb 2022 | 4 Years 8 Months | Current |
| Pramodita | Director | 23 Feb 2022 | 4 Years 8 Months | Current |
| Saravanan Mahalakshmi | Director | 29 Jul 2021 | 5 Years 2 Months | Current |
Peer comparison
Inba Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saroj Medicare Private Limited | ₹88.44 Lakh (FY 2024) | 0.0% | Jodhpur, Rajasthan, India | |||
| Inba Pharma Private Limitedthis company | ₹87.93 Lakh (FY 2024) | -₹4.36 Lakh | -5% | -65.0% | Chennai, Tamil Nadu, India | |
| Lorven Medicare Private Limited | ₹87.79 Lakh (FY 2025) | 10.0% | Hyderabad, Telangana, India | |||
| Three Wise Men Healthcare Private Limited | ₹87.74 Lakh (FY 2025) | 69.0% | Nagpur, Maharashtra, India | |||
| Barouda Mediserve Private Limited | ₹87.7 Lakh (FY 2021) | 39.0% | Jaipur, Rajasthan, India | |||
| Om Patliputra Emergency Hospital Private Limited | ₹87.65 Lakh (FY 2023) | -7.0% | Bhagbhat Nagar, Bihar, India |
To see the full peer comparison of Inba Pharma Private Limited, buy the company report.
Auditor
Inba Pharma Private Limited is audited by Anand and Ponnappan for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Anand and Ponnappan | FY 2024 | 000111S |
Shareholding
The shareholding of Inba Pharma Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Inba Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Inba Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inba Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inba Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAVCA5534F1ZL | Tamil Nadu | Active | 11 Feb 2025 |
| 36AAVCA5534F1ZF | Telangana | Active | 11 Aug 2021 |
To see the full GST registrations and return filing status of Inba Pharma Private Limited, buy the company report.
Recent activity
Inba Pharma Private Limited has 6 board changes on record since 2021: 3 appointments and 3 cessations. The latest: Joshitt ceased to be Additional Director on 27 Sep 2022.
Frequently asked questions
Inba Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in hospitals, within the healthcare industry. It was incorporated on 29 July 2021 (5+ years old) and is registered under CIN U85300TN2021PTC145107.
Inba Pharma has 3 current directors:
- Joshitt - Director
- Pramodita - Director
- Saravanan Mahalakshmi - Director
The latest financial statements of Inba Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Inba Pharma is 33AAVCA5534F1ZL, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAVCA5534F1ZF (Telangana).
The CIN (Corporate Identification Number) of Inba Pharma is U85300TN2021PTC145107. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inba Pharma was incorporated on 29 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Inba Pharma by revenue are Saroj Medicare Private Limited, Lorven Medicare Private Limited, Three Wise Men Healthcare Private Limited, Barouda Mediserve Private Limited, Om Patliputra Emergency Hospital Private Limited, all in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities).
Joshitt ceased to be Additional Director on 27 Sep 2022. Pramodita ceased to be Additional Director on 27 Sep 2022. Lakshmanan Saravanan ceased to be Director on 25 Feb 2022. Inba Pharma has 6 board changes on record in total.
The registered office of Inba Pharma is at No.50 & 51 3rd Street Balajinagar Padi, Chennai, Tamil Nadu, India – 600050.
Inba Pharma operates in the healthcare industry, in the hospitals segment.
Inba Pharma can be reached at its registered office: No.50 & 51 3rd Street Balajinagar Padi, Chennai, Tamil Nadu, India – 600050.